Raymond James & Associates’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Raymond James & Associates’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,562	Closed	-$757K	–	3898
2020 Q3	$757K	Sell	18,562 -11	-0.1%	-$548	﹤0.01%	2347
2020 Q2	$1.02M	Sell	18,573 -2,831	-13%	-$162K	﹤0.01%	2152
2020 Q1	$1.12M	Sell	21,404 -2,522	-11%	-$137K	﹤0.01%	1906
2019 Q4	$1.17M	Buy	23,926 +18,160	+315%	+$850K	﹤0.01%	2179
2019 Q3	$317K	Sell	5,766 -208	-3%	-$11.9K	﹤0.01%	2973
2019 Q2	$298K	Buy	5,974 +89	+2%	+$4.43K	﹤0.01%	3020
2019 Q1	$332K	Buy	5,885 +1,901	+48%	+$113K	﹤0.01%	2924
2018 Q4	$254K	Sell	3,984 -353	-8%	-$25K	﹤0.01%	2969
2018 Q3	$352K	Buy	4,337 +698	+19%	+$51.1K	﹤0.01%	2939
2018 Q2	$232K	Buy	+3,639	New	+$178K	﹤0.01%	3177
2017 Q3	–	Sell	-58,750	Closed	-$884K	–	3509
2017 Q2	$884K	Buy	+58,750	New	+$793K	﹤0.01%	2101

Other funds holding TRHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James & Associates's TRHC Position: Q4 2020 in Review

Raymond James & Associates sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2020, closing a stake of 18,562 shares — an estimated $757K sold.

Raymond James & Associates first reported a position in TRHC in Q2 2017 and held it in 11 quarters. The position peaked at $1.17M in Q4 2019. 163 funds tracked by Wall St. Rank hold TRHC as of Q4 2020.

Raymond James & Associates reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Raymond James & Associates sold 18,562 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2020, an estimated $757K.
Raymond James & Associates first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q2 2017 and held it in 11 quarters.
Raymond James & Associates's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $1.17M in Q4 2019.
163 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2020.

Based on Raymond James & Associates's 13F filing for Q4 2020, filed 12 Feb 2021.